News Column

DEPOMED INC FILES (8-K) Disclosing Regulation FD Disclosure, Financial Statements and Exhibits

September 2, 2014

Item 7.01. Regulation FD Disclosure.

On September 2, 2014, Depomed Inc. (the "Company") announced that it commenced an offering of $230 million aggregate principal amount of Convertible Senior Notes due 2021 (the "Notes"), subject to market and other conditions. The Notes are being offered pursuant to an effective shelf registration statement that has been filed with the Securities and Exchange Commission.

A copy of the Company's press release is attached hereto as Exhibit 99.1 and is incorporated by reference herein.

Item 9.01. Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description of Exhibit

99.1 Press Release, dated September 2, 2014. 2


For more stories on investments and markets, please see HispanicBusiness' Finance Channel

Source: Edgar Glimpses

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters